India’s leading health-tech startup has collaborated with the international NGO PATH, to accelerate and intensify COVID-19 screening by making advanced AI diagnostic technology available to physicians across India through the Telegram App.
Back
Qure’s CE-certified AI solution can read and interpret chest X-ray to detect findings indicative of COVID-19 as well as quantify the proportion of lungs affected due to the lesions. The technology which is being used by the Mumbai Municipal corporation and super-specialty hospitals across the globe, is now available to physicians on the Telegram app.
The second wave in India has led to a sharp scarcity of RT-PCR tests, as well as delayed reporting and lower accuracy in the test’s results. Qure’s AI solution can help as a preliminary screening mechanism.
Chest X-rays are being increasingly preferred to assess and quantify the infection in the lungs as they are more easily available, inexpensive and inflict lower radiation levels. Qure’s AI bot would enable clinicians to triage for COVID-19 instantaneously.
Physicians would only have to download the Qure bot from the Telegram app, upload the patient’s chest X-rays either as DICOMs images or as images taken by the smartphone camera. The result would be available in less than a minute and would serve as a second opinion or confirmation of diagnosis.
PATH is an international NGO which has been on the forefront of enabling digital transformation in India. Working with various state governments, they have a strong history of improving the effectiveness of health programs in 22+ states through their network of physicians and healthcare workers.
Prashant Warier, CEO and co-founder of Qure.ai said “What we’ve been seeing in the last few weeks is truly taking a toll on our frontline care givers and straining our public and private healthcare infrastructure severely. We need to implement and leverage technology that’s been extensively trained and validated to tackle this ongoing tragedy fast and it needs to be now.”
Dr. Shibu Vijayan, Global TB Technical Director, PATH said “Qure’s technology detects ground-glass opacities and consolidation, which are indicative of COVID-19 infections. It quantifies affected lung volume and gives a COVID-19 score which will help physicians decide on the course of treatment. It will also help healthcare institutions with optimizing their resource allocation.”
